Oric Pharmaceuticals, Inc. ORIC Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oric Pharmaceuticals, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oric Pharmaceuticals, Inc.'s accrued expenses?
- Oric Pharmaceuticals, Inc. (ORIC) reported accrued expenses of $14.88M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s accrued expenses changed year-over-year?
- Oric Pharmaceuticals, Inc.'s accrued expenses increased by 19.4% year-over-year, from $12.46M to $14.88M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Oric Pharmaceuticals, Inc.'s accrued expenses has grown at a 15.0% compound annual growth rate (CAGR), from $8.25M to $16.59M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.